Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$11.45 - $13.96 $1.49 Million - $1.81 Million
-129,800 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$11.06 - $12.87 $211,964 - $246,653
-19,165 Reduced 12.87%
129,800 $1.55 Million
Q4 2020

Feb 02, 2021

SELL
$9.33 - $12.48 $14,274 - $19,094
-1,530 Reduced 1.02%
148,965 $1.85 Million
Q3 2020

Nov 05, 2020

BUY
$10.33 - $14.49 $60,533 - $84,911
5,860 Added 4.05%
150,495 $1.57 Million
Q2 2020

Aug 12, 2020

BUY
$11.49 - $15.26 $1,562 - $2,075
136 Added 0.09%
144,635 $2.02 Million
Q1 2020

May 12, 2020

SELL
$8.11 - $15.23 $1.27 Million - $2.39 Million
-157,060 Reduced 52.08%
144,499 $1.7 Million
Q4 2019

Jan 27, 2020

BUY
$10.28 - $14.38 $1.57 Million - $2.19 Million
152,391 Added 102.16%
301,559 $4.27 Million
Q3 2019

Oct 31, 2019

BUY
$10.05 - $14.55 $184,658 - $267,341
18,374 Added 14.05%
149,168 $1.57 Million
Q2 2019

Aug 15, 2019

SELL
$13.1 - $14.95 $198,884 - $226,970
-15,182 Reduced 10.4%
130,794 $1.9 Million
Q1 2019

May 03, 2019

BUY
$13.69 - $20.06 $65,465 - $95,926
4,782 Added 3.39%
145,976 $2.05 Million
Q4 2018

Feb 08, 2019

SELL
$13.96 - $18.26 $87,948 - $115,038
-6,300 Reduced 4.27%
141,194 $2.46 Million
Q3 2018

Nov 13, 2018

SELL
$13.63 - $15.7 $177,258 - $204,178
-13,005 Reduced 8.1%
147,494 $2.25 Million
Q2 2018

Aug 15, 2018

SELL
$13.44 - $17.59 $436,813 - $571,692
-32,501 Reduced 16.84%
160,499 $2.22 Million
Q1 2018

May 11, 2018

SELL
$13.8 - $16.99 $114,540 - $141,017
-8,300 Reduced 4.12%
193,000 $3.22 Million
Q4 2017

Feb 06, 2018

SELL
$11.73 - $14.75 $5,865 - $7,375
-500 Reduced 0.25%
201,300 $2.86 Million
Q3 2017

Nov 15, 2017

BUY
$12.06 - $14.12 $2.43 Million - $2.85 Million
201,800
201,800 $2.85 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.